FDA - Blog - A2-Ai

All posts Tag / FDA

Categories

case studies news products research spotlights services tooling updates

Tags

2025 ADME Aging AI animal testing approval process Cardiac Safety clinical pharmacology Clinical Research clinical trials Clinical Trials cloud platform

MIDD - FDA Has Officially Announced Their Roadmap to Phase Out Animal Testing for Monoclonal Antibodies

Simonne Bruck April 30, 2025

servicescase studies

Accelerating FDA Approval with MIDD: How A2-Ai Secured a New Dose Without a Phase 3 Trial

Eric Storms November 14, 2025

IND Services - We Support and Assist You in IND Applications to Streamline the FDA Approval Process

Simonne Bruck February 28, 2025

Links

Home Leadership Careers Contact Blog

Science

FDA Project Optimus Preclinical Support Clinical Pharmacology Pharmacometrics Education

Technology

Overview A2-Ai Cloud Alexandria PharmaSage

Resources

Community

LinkedIn GitHub RSS

A2-Ai is a premier full-service consultancy run by leaders who put science and patients first, with a focus on providing true value to our clients.

® A2-Ai LLC 2025

2723 S. State Street
Suite 310
Ann Arbor, MI 48104